Answers are grounded in this paper and cite their sources.
Prospective analysis evaluates dietary phytoestrogens and breast cancer risk in postmenopausal women, suggesting subtype-specific implications.
BACKGROUND: Phytoestrogens may influence breast carcinogenesis through hormone-related and non-hormone-mediated mechanisms, yet prospective evidence by receptor-defined subtype in U.S. populations remains limited. We evaluated associations between dietary phytoestrogen intake and risk of estrogen receptor (ER), progesterone receptor (PR), and HER2-defined breast cancer. METHODS: We analyzed 51,530 postmenopausal women in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Baseline intake of total and individual phytoestrogens was assessed using a validated food frequency questionnaire. Incident breast cancers were classified by ER, PR, and HER2 status. Cause-specific Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) across tertiles of intake, adjusting for established breast cancer risk factors. RESULTS: During follow-up, 2,364 incident breast cancers were identified. Higher coumestrol intake was associated with lower hazard of ER- breast cancer (tertile 3 vs. tertile 1: HR 0.67; 95% CI, 0.50-0.91; p-trend=0.014) and PR- breast cancer (HR 0.74; 95% CI, 0.59-0.93; p-trend=0.013). Higher total isoflavone intake was associated with lower hazard of HER2-positive disease (HR 0.62; 95% CI, 0.45-0.87; p-trend=0.005), with similar findings for daidzein. No significant associations were observed for ER+ or PR+ tumors. CONCLUSIONS: Associations between phytoestrogen intake and breast cancer differed by receptor-defined subtype, with inverse associations observed primarily for receptor-negative and HER2-positive tumors. IMPACT: These findings suggest that associations between dietary phytoestrogen intake and breast cancer may vary across receptor-defined subtypes and highlight the need for replication using biomarker-based measures and populations with higher exposure levels.
No takes yet. Share an insight, caveat, or question.
Reger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: